NEFL antibody
- Known as:
- NEFL (anti-)
- Catalog number:
- orb66923
- Product Quantity:
- EUR
- Category:
- -
- Supplier:
- Biorbyt biorb
- Gene target:
- NEFL antibody
Related genes to: NEFL antibody
- Gene:
- NEFL NIH gene
- Name:
- neurofilament light
- Previous symbol:
- -
- Synonyms:
- NFL, CMT1F, CMT2E, NF68, PPP1R110
- Chromosome:
- 8p21.2
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2019-04-23
Related products to: NEFL antibody
Related articles to: NEFL antibody
- Immune dysfunction has been implicated in Alzheimer's disease (AD), but the roles of specific immunoglobulin classes remain unclear. - Source: PubMed
Peng ShihuiButler-Laporte GuillaumeJohnson Sterling CEngelman Corinne DLu Tianyuan - Central nervous system (CNS) dysfunction is increasingly recognized in hereditary transthyretin (ATTRv) amyloidosis. We aimed to characterize CNS manifestations and assess associations with clinical variables and plasma neurofilament light chain (NfL), using history of transient focal neurological episodes (TFNEs) as the main outcome. - Source: PubMed
Publication date: 2026/09/20
Sousa LuísaCoelho TeresaFernandes JoanaCardoso MárcioAlves Cristinada Silva Ana MartinsSousa Ana PaulaPinto Miguel MendonçaPereira Rafael ManiésRuano LuísLemos CarolinaBaldeiras InêsReis CarolinaTaipa Ricardo - Mild cognitive impairment (MCI) is clinically and etiologically heterogeneous. We aimed to develop and externally validate a multimodal model for distinguishing clinically defined MCI from normal cognition using plasma biomarkers and diffusion tensor imaging (DTI)-derived white-matter features. - Source: PubMed
Publication date: 2026/09/18
Ke JiayuXuekelati SaiyareMaimaitiwusiman ZhuoyaHalan BuluhanXu QihongGuo ShukeXu LeiWang Hongmei - Hypertension is associated with cognitive impairment, and cerebral microbleeds (CMBs) may reflect hemorrhagic small-vessel injury. We examined whether CMB burden and location were associated with global and domain-specific cognition in adults with primary hypertension and whether serum neurofilament light chain (sNFL) provided additional discrimination for identifying mild cognitive impairment (MCI) beyond CMB count. - Source: PubMed
Publication date: 2026/09/03
Li ZiyinZhao XiaobinZhou DandanZhao Cui - Despite achieving NEDA‑3, a substantial proportion of patients with multiple sclerosis (MS) accumulate disability through progression independent of relapse activity (PIRA). This scoping review evaluates serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in relation to disease activity and progression, with particular focus on the effects of age, BMI, and renal function on biomarker interpretation. - Source: PubMed
Publication date: 2026/09/17
Kadirova Aziza ShavkatovnaRakhmatullaeva Gulnora KutpitdinovnaSalimjonov Javlon Jasur Ugli